Fresenius reported €2.76B in Cash and Equivalent for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Akzo Nobel AKZA:NA € 1152M 65M
Alcon AG ALC:SW 1.58B 10M
AstraZeneca AZN:LN 6329M 738M
BASF BAS:GR € 2899M 30M
Bayer BAYN:GR € 4564M 248M
E.ON EOAN:GR 4.26B 2.72B
Fresenius FRE:GR € 2764M 351M
Getinge GETIB:SS SK 4076M 578M
Givaudan GIVN:VX 273M 33M
GRIFOLS GRF:SM € 397.86M 16.88M
Hikma Pharmaceutical HIK:LN 426M 424M
Lonza Group LONN:SW 1.58B 1.08B
Novartis NOVN:VX SF 12407M 5196M
Philips PHIA:NA € 2303M 1524M
RWE RWE:GR € 3576M 3467M